GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DakLak Pharmaceutical Medical Equipment JSC (HSTC:DBM) » Definitions » EBIT

DakLak Pharmaceutical Medical Equipment JSC (HSTC:DBM) EBIT : ₫ Mil (TTM As of . 20)


View and export this data going back to 2009. Start your Free Trial

What is DakLak Pharmaceutical Medical Equipment JSC EBIT?

DakLak Pharmaceutical Medical Equipment JSC's earnings before interest and taxes (EBIT) for the six months ended in . 20 was ₫0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

DakLak Pharmaceutical Medical Equipment JSC EBIT Historical Data

The historical data trend for DakLak Pharmaceutical Medical Equipment JSC's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DakLak Pharmaceutical Medical Equipment JSC EBIT Chart

DakLak Pharmaceutical Medical Equipment JSC Annual Data
Trend
EBIT

DakLak Pharmaceutical Medical Equipment JSC Semi-Annual Data
EBIT

Competitive Comparison of DakLak Pharmaceutical Medical Equipment JSC's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, DakLak Pharmaceutical Medical Equipment JSC's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DakLak Pharmaceutical Medical Equipment JSC's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DakLak Pharmaceutical Medical Equipment JSC's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where DakLak Pharmaceutical Medical Equipment JSC's EV-to-EBIT falls into.


DakLak Pharmaceutical Medical Equipment JSC EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in . 20 was ₫ Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DakLak Pharmaceutical Medical Equipment JSC  (HSTC:DBM) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

DakLak Pharmaceutical Medical Equipment JSC's annualized ROC % for the quarter that ended in . 20 is calculated as:

ROC % (Q: . 20 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: . 20 ) + Invested Capital (Q: . 20 ))/ count )
= * ( 1 - % )/( ( + )/ )
=/
= %

where

Invested Capital(Q: . 20 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
= - - ( - max(0, - +))
=

Invested Capital(Q: . 20 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
= - - ( - max(0, - +))
=

Note: The Operating Income data used here is one times the annual (. 20) data.

2. Joel Greenblatt's definition of Return on Capital:

DakLak Pharmaceutical Medical Equipment JSC's annualized ROC (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

ROC (Joel Greenblatt) %(Q: . 20 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: . 20  Q: . 20
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=/( ( ( + max(, 0)) + ( + max(, 0)) )/ )
=/( ( + )/ )
=/
= %

where Working Capital is:

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (. 20) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

DakLak Pharmaceutical Medical Equipment JSC's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: . 20 )
=/0.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DakLak Pharmaceutical Medical Equipment JSC EBIT Related Terms

Thank you for viewing the detailed overview of DakLak Pharmaceutical Medical Equipment JSC's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

DakLak Pharmaceutical Medical Equipment JSC Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DakLak Pharmaceutical Medical Equipment JSC (HSTC:DBM) » Definitions » EBIT
Comparable Companies
Traded in Other Exchanges
N/A
Address
9A Hung Vuong, Tu An Ward, Dak Lak Province, Buon Ma Thuot, VNM
Website
https://www.bamepharm.com.vn
DakLak Pharmaceutical Medical Equipment JSC is engaged in producing medicines for human diseases, nutritional food products, drugs derived from medicinal herbs. It is also engaged in the export and import of drugs, pharmaceutical materials, and medical equipment.

DakLak Pharmaceutical Medical Equipment JSC Headlines

No Headlines